Water disinfection model (Sodium bromate): Target Organs and Levels of Evidence for GMM-06
Toxicology Studies of Sodium Bromate (CASRN 7789-38-0) in Genetically Modified (FVB Tg.AC Hemizygous) Mice (Dermal and Drinking Water Studies) and Carcinogenicity Studies of Sodium Bromate in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Drinking Water Studies)
Chemical (Study Title) CASRN | Peer Review Date | Route/Exposure Levels | Study Laboratory |
---|---|---|---|
Water disinfection model (Sodium bromate) 7789-38-0 | 09/27/2005 | Dosed-Water 0, 80, 400, or 800 mg/L | Battelle Columbus Laboratory |
Male P53 Haploinsufficient Mice | Female P53 Haploinsufficient Mice | |||
---|---|---|---|---|
27 Weeks | 43 Weeks | 27 Weeks | 43 Weeks | |
Levels of Evidence | No Evidence | No Evidence | No Evidence | No Evidence |
Neoplastic | None | None | None | None |
Non-Neoplastic | None | None | None | None |
Male Tg.AC Hemizygous Mice | Female Tg.AC Hemizygous Mice | |||
---|---|---|---|---|
27 Weeks | 43 Weeks | 27 Weeks | 43 Weeks | |
Neoplastic | None | None | None | None |
Non-Neoplastic Lesions |
|
|
|
|
Chemical (Study Title) CASRN | Peer Review Date | Route/Exposure Levels | Study Laboratory |
---|---|---|---|
Water disinfection model (Sodium bromate) 7789-38-0 | 09/27/2005 | Topical Application 0, 64, 128, or 256 mg/kg | Battelle Columbus Laboratory |
Male Tg.AC Hemizygous Mice | Female Tg.AC Hemizygous Mice | |||
---|---|---|---|---|
26 Weeks | 39 Weeks | 26 Weeks | 39 Weeks | |
Neoplastic | None | None | None | None |
Non-Neoplastic Lesions |
|
|
|
|